Live Case Broadcasting from Sunnybrook Hospital | Toronto, CA

Saturday, March 8, 2025

11:32 AM – 12:30 PM ET

Live Case Operator(s)

Harindra C. Wijeysundera, MD, PhD

Professor, Chief of Heart Program
Sunnybrook Health Sciences Center
Toronto, Ontario, Canada

Disclosure(s): No financial relationships to disclose

Moderator(s)

Carlo Di Mario, MD

Professor
University of Florence
Florence, Toscana, Italy

Disclosure(s): BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, Regeneron: Grant/Research Support (Terminated, September 7, 2023)
Allison B. Hall, MD, FRCPC

Interventional Cardiologist, Clinical Assistant Professor of Medicine
NL Health Services/Memorial University of Newfoundland
St. John's, Newfoundland and Labrador, Canada

Disclosure information not submitted.
Jacques J. Koolen, MD, PhD, FSCAI

cardiologist
Catharina Hospital
Amsterdam, Noord-Holland, Netherlands

Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

Lorenzo Azzalini, MD, PhD, MSc

Interventional Cardiologist
University of Washington
Seattle, Washington, United States

Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing); Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); GE Healthcare: Consulting Fees (e.g., advisory boards) (Terminated, December 11, 2024); HeartFlow: Consulting Fees (e.g., advisory boards) (Ongoing); Reflow Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Shockwave Medical, Inc: Consulting Fees (e.g., advisory boards) (Ongoing); Teleflex: Consulting Fees (e.g., advisory boards) (Ongoing)
Kathryn Dawson, MD

Interventional Cardiologist
Providence Heart and Vascular Institute
Portland, Oregon, United States

Disclosure(s): No financial relationships to disclose
Jarrod Frizzell, MD, MS

Director, Complex Coronary Therapeutics Program
St George’s University Hospitals NHS Foundation Trust
Cincinnati, Ohio, United States

Disclosure(s): Asahi Intecc, Japan: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientifiic: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Reflow Medical: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Shockwave Medical: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Robert Gallino, MD

Co Director of CTO program at MWHC
Cardiology Associates, LLC
Olney, Maryland, United States

Disclosure information not submitted.
Srini Potluri, MD

Chief of Cardiology
Baylor Scott and White The Heart Hospital Plano
Frisco, Texas, United States

Disclosure information not submitted.
Tanveer Rab, MD, FACC, MSCAI

Professor
Emory University
Decatur, Georgia, United States

Disclosure(s): No financial relationships to disclose
Stephane Rinfret, MD, SM

Director of Complex Coronary Interventions
Georgia Heart Institute
Gainesville, Georgia, United States

Disclosure information not submitted.
Alpesh Shah, MD

Director of Coronary Interventions, Associate Professor
Houston Methodist Hospital
Houston, Texas, United States

Disclosure information not submitted.
Angela M. Taylor, MD, MS, MBA

Professor
University of Virginia
Charlottesville, Virginia, United States

Disclosure information not submitted.
Masahisa Yamane, MD

Senior Advisor
Saitama Sekishinkai Hospital
Tokyo, Tokyo, Japan

Disclosure(s): Asahi Intecc, Japan: Consulting Fees (e.g., advisory boards) (Ongoing)

Disclosure(s):

Harindra C. Wijeysundera, MD, PhD: No financial relationships to disclose

Bradley H. Strauss, MD, PhD: RBY Medical: company founder (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Carlo Di Mario, MD: BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, Regeneron: Grant/Research Support (Terminated, September 7, 2023)

Jacques J. Koolen, MD, PhD, FSCAI: No financial relationships to disclose

Lorenzo Azzalini, MD, PhD, MSc: Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing); Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); GE Healthcare: Consulting Fees (e.g., advisory boards) (Terminated, December 11, 2024); HeartFlow: Consulting Fees (e.g., advisory boards) (Ongoing); Reflow Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Shockwave Medical, Inc: Consulting Fees (e.g., advisory boards) (Ongoing); Teleflex: Consulting Fees (e.g., advisory boards) (Ongoing)

Kathryn Dawson, MD: No financial relationships to disclose

Tanveer Rab, MD, FACC, FSCAI: No financial relationships to disclose

Masahisa Yamane, MD: Asahi Intecc, Japan: Consulting Fees (e.g., advisory boards) (Ongoing)